The Ticker
Boston Herald - United States
... and Biogen Idec said they asked US regulators to approve
use of their multiple sclerosis drug Tysabri, which has been
hurt by safety concerns, to treat the ...

Elan, Biogen seek OK to sell Tysabri for Crohn's
Reuters - USA
... and Biogen Idec (BIIB.O: Quote, Profile , Research) on
Friday said they asked US regulators to approve use of
their multiple sclerosis drug Tysabri, which has ...
See all stories on this topic